Today's top medical abstracts
Internal Med
Become a Member Today!
Email
Password
Remember me
Forgot your Password?

Invite Code?

Home
General Internal Med
Messages
Conferences
Jobs
Newsletters
My Library
Topics in
Internal Med
        Academic Med/Education
        Adolescent Medicine
        Allergy/Immunology
        Atherosclerosis/Lipids
        Basic Science/Genetics
        Cardiology
        Clinical Pharmacology
        Complementary Medicine
        Critical Care/
    Hospitalist
        Dermatology
        Economics of Medicine
        Endocrinology
        Epidemiology
        Gastroenterology
        Geriatrics
        Hematology/Oncology
        Infectious Disease
        Nephrology/Urology
        Neurology
        Orthopedic/Physical Med
        Popular Press
        Preventive Medicine
        Primary Care
        Psychiatry
        Pulmonology
        Radiology/Diagnostics
        Rheumatology
        Sports Medicine
        Vascular Medicine
        Women`s Health
 
Help
Resource Center
RSS News Feeds
Send Newsletter
to a Friend
 
Sponsor
Cancer Science: #14. Does Size Matter? "Stumpy" Telomeres Allow Cancer Cells to Evade Senescence
Sara Hartley, MDLinx Oncology
  See all
Radical prostatectomy Article Summary

Click the title below to leave the MDLinx Network and go to the Journal's Website
Quantification of PSA mRNA levels in peripheral blood of patients with localized prostate adenocarcinoma before, during, and after radical prostatectomy by quantitative real-time PCR (qRT-PCR)
International Urology and Nephrology, 07/03/08
Print     Email This Article     Save in My Library   Free Abstract
Kalfazade N et al. - In a study to evaluate the clinical value of detected prostate-specific antigen (PSA) mRNA expression levels in circulating cells in pts with prostate cancer by qRT-PCR and determine the effect of surgical manipulation on hematogenous dissemination, it seems that highly detectable PSA mRNA expression levels in preoperative samples seem to be a significant predictable factor for prostate cancer recurrence

Methods
  • Blood samples before, during, and after (24 h) surgery were obtained from 34 pts with prostate cancer who underwent radical prostatectomy for detecting PSA mRNA expression levels
  • PSA mRNA expression levels, PSA levels, and Gleason scores were then compared

Results
  • PSA mRNA expression levels were detected in 14 of 34 pts, and biochemical recurrence of blood PSA was observed in 6 of 34 pts
  • Differences of PSA mRNA expression levels in pre-, per-, and postoperative periods were statistically significant and differences of PSA mRNA expression levels in pre- and peroperative samples, pre- and postoperative samples, and per- and postoperative samples were also statistically meaningful
  • There was significant relationship between the detectable PSA mRNA expression levels in preoperative samples and biochemical recurrence of blood PSA levels
  • Surgical manipulation had no effect on biochemical recurrence of blood PSA
  • There was significant correlation between high Gleason score and the detectable PSA mRNA expression levels

Sponsor
Read a Different Specialty
Allergy/Immunology
Anesthesiology
Cardiology
Dermatology
Drugs
Emergency Medicine
Endocrinology
ENT
Family Medicine
Gastroenterology
Hematology-Oncology
Infectious Disease
Internal Medicine
Nephrology
Neurology
OB/Gyn
Ophthalmology
Orthopedics
Pediatrics
Psychiatry
Pulmonology
Radiology
Rheumatology
Surgery
Urology
Profession Index
Dentist
Hospital Administrator
Nurse
    Medical Students
Nurse Practitioner
Pharma/Drug Marketer
    Pharmacist
Physician
Physician Assistants
Article Search
Keyword:
Search:
Published within:
Sort By:
Date Relevance
    
Sponsor
About MDLinx  |  Contact  |  Advertise with MDLinx  |  Site Map  |  Privacy Policy  |  Terms of Use  |  Sign Up For Newsletters  |  Recommend this Site

English |  Español |  Français |  Deutsch |  中文 |  Руccкий |  Norsk |  Nederlands |  Português |  Italiano

©1999-2008 MDLinx, Inc.